Fauci: Borrowed Cash Won't Carry Zika Efficacy Trials

Cash borrowed from various US government programs, including the Ebola response, is enough to get at least two Phase I Zika vaccine trials underway, but those funds won't carry the efficacy studies – the preparations of which must get off the ground next month. So Congress needs to allocate new dollars within the next few weeks or the Phase II trials will be in jeopardy, Anthony Fauci, the nation's top infectious disease official, told Scrip.

Zika

While the US National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has enough funds – albeit borrowed from other programs – to start a Phase I trial of an experimental Zika virus vaccine next month and even bring it to fruition, if Congress fails to allot new dollars within the next few weeks, a Phase IIb study may never get off the ground, or at least, be significantly delayed, the agency's chief said.

Anthony Fauci, director of the NIAID, told Scrip the agency expects to now initiate the Phase I study testing the...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip